The National Academy of Medicine announced the election of 100 new members to join their esteemed ranks in 2023, among them five MIT faculty members and seven additional affiliates. MIT professors Daniel Anderson, Regina Barzilay, Guoping Feng, Darrell Irvine, and Morgen Sheng were among the new members. Justin Hanes PhD ’96, Said Ibrahim MBA ’16, and Jennifer West ’92, along…
Alzheimer’s disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the disease. In hopes of discovering new targets for potential Alzheimer’s treatments, MIT researchers have performed the broadest analysis yet of the genomic, epigenomic, and transcriptomic changes that occur in every cell type in the…
Huge libraries of drug compounds may hold potential treatments for a variety of diseases, such as cancer or heart disease. Ideally, scientists would like to experimentally test each of these compounds against all possible targets, but doing that kind of screen is prohibitively time-consuming. In recent years, researchers have begun using computational methods to screen those libraries in hopes of…
Your brain is powered by 400 miles of blood vessels that provide nutrients, clear out waste products, and form a tight protective barrier — the blood-brain barrier — that controls which molecules can enter or exit. However, it has remained unclear how these brain vascular cells change between brain regions, or in Alzheimer’s disease, at single-cell resolution. To address this…
Thirteen MIT undergraduates, graduate students, and alumni have been awarded Fulbright fellowships and will embark on projects overseas in the 2023-24 grant year. Four other MIT affiliates were offered awards but declined them to pursue other opportunities. Sponsored by the U.S. Department of State, the Fulbright U.S. Student Program offers American citizen students and recent alumni year-long grants for independent…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More